This inventor holds 7 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Day Three Labs Manufacturing Inc., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Izun Pharmaceuticals Corporation. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nehusha, IL (2020 - 2023)
- Nehosha, IL (2020 - 2024)
Company Filing History:
4 out of 6 
2 out of 916 
1 out of 16 
Years Active: 2020-2024
Title: Shmuel Cohen: Innovator in Cannabinoid Research
Introduction
Shmuel Cohen is a notable inventor based in Nehosha, Illinois. He has made significant contributions to the field of cannabinoid research, holding a total of 7 patents. His work focuses on innovative methods for producing cannabinoid compositions that have potential therapeutic applications.
Latest Patents
Cohen's latest patents include groundbreaking inventions such as water-based cannabinoid and opioid compositions. This invention relates to methods for manufacturing a protein-bound cannabinoid by combining various forms of cannabis with an aqueous solution containing plasma protein. Another significant patent is for stabilized protein-bound cannabinoid compositions, which involves creating a fatty acid-cannabinoid-plasma protein complex. This method enhances the stability and efficacy of cannabinoid formulations.
Career Highlights
Throughout his career, Shmuel Cohen has worked with prominent companies in the research and development sector. Notable among these are Day Three Labs Manufacturing Inc. and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work in these organizations has contributed to advancements in cannabinoid applications.
Collaborations
Cohen has collaborated with esteemed colleagues, including William Zev Levine and David Naor. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Shmuel Cohen's contributions to cannabinoid research exemplify the intersection of innovation and healthcare. His patents reflect a commitment to advancing therapeutic options through scientific exploration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile